Status:
UNKNOWN
Evaluating the Chain of Addiction Care (CAC)
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
AbbVie
Gilead Sciences
Conditions:
Hepatitis C, Chronic
Substance Use Disorders
Eligibility:
All Genders
18+ years
Brief Summary
The investigators want to evaluate the feasibility of a decentralised hepatitis C care pathway (the Chain of Addiction Care (CAC) pathway) in several addiction care centres in the east of the Netherla...
Detailed Description
People who (have) inject(ed) drugs (PWID) are at high risk for hepatitis C infection. Establishing adequate linkage to care in this population can be a challenge. Many of these patients receive opioid...
Eligibility Criteria
Inclusion
- Aged 18 years or older
- Able and willing to give informed consent
- Currently inject or previously injected drugs at least once, including nasal snorting of drugs using aids such as basepipes or straws.
- Visit the participating addiction care centre at least once during the study period
Exclusion
- none
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05401136
Start Date
March 1 2020
End Date
December 1 2023
Last Update
June 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525GA